Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianming Deng

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 24, 2023
Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissuesHan Gao, Shiqi Wang, Qiang Long, et al.
Organic Letters|May 30, 2023
Exploring Diversity through Dimerization in Natural Products by a Rational Tandem Mass-Based Molecular Network StrategyLi Li, Yuezhou Wang, Naixin Chen, et al.
Acta Pharmaceutica Sinica. B|February 13, 2026
Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1Taoling Zeng, Tingting Jiang, Baoding Zhang, et al.
Journal of Medicinal Chemistry|June 8, 2018
Discovery and Identification of Small Molecules as Methuosis Inducers with in Vivo Antitumor ActivitiesWei Huang, Xihuan Sun, Yunzhan Li, et al.
Cancer Research|August 24, 2018
A Novel Microtubule Inhibitor Overcomes Multidrug Resistance in TumorsNannan Ning, Yamei Yu, Min Wu, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilmsXiaoli Zhu, Anjin Hong, Xihuan Sun, et al.
Cell Reports|June 21, 2016
Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin SignalingSo-Young Hwang, Xianming Deng, Sanguine Byun, et al.
Signal Transduction and Targeted Therapy|May 24, 2022
PIKfyve inhibitors against SARS-CoV-2 and its variants including OmicronJingyi Su, Jing Zheng, Wei Huang, et al.
Neurochemistry International|November 14, 2022
Efficacy of novel SPAK inhibitor ZT-1a derivatives (1c, 1d, 1g & 1h) on improving post-stroke neurological outcome and brain lesion in miceMohammad Iqbal H Bhuiyan, Sydney Fischer, Shivani M Patel, et al.
The Journal of Experimental Medicine|October 13, 2017
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disordersHua Jiang, Hongbin He, Yun Chen, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 24, 2023
Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissuesHan Gao, Shiqi Wang, Qiang Long, et al.
Organic Letters|May 30, 2023
Exploring Diversity through Dimerization in Natural Products by a Rational Tandem Mass-Based Molecular Network StrategyLi Li, Yuezhou Wang, Naixin Chen, et al.
Acta Pharmaceutica Sinica. B|February 13, 2026
Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1Taoling Zeng, Tingting Jiang, Baoding Zhang, et al.
Journal of Medicinal Chemistry|June 8, 2018
Discovery and Identification of Small Molecules as Methuosis Inducers with in Vivo Antitumor ActivitiesWei Huang, Xihuan Sun, Yunzhan Li, et al.
Cancer Research|August 24, 2018
A Novel Microtubule Inhibitor Overcomes Multidrug Resistance in TumorsNannan Ning, Yamei Yu, Min Wu, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilmsXiaoli Zhu, Anjin Hong, Xihuan Sun, et al.
Cell Reports|June 21, 2016
Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin SignalingSo-Young Hwang, Xianming Deng, Sanguine Byun, et al.
Signal Transduction and Targeted Therapy|May 24, 2022
PIKfyve inhibitors against SARS-CoV-2 and its variants including OmicronJingyi Su, Jing Zheng, Wei Huang, et al.
Neurochemistry International|November 14, 2022
Efficacy of novel SPAK inhibitor ZT-1a derivatives (1c, 1d, 1g & 1h) on improving post-stroke neurological outcome and brain lesion in miceMohammad Iqbal H Bhuiyan, Sydney Fischer, Shivani M Patel, et al.
The Journal of Experimental Medicine|October 13, 2017
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disordersHua Jiang, Hongbin He, Yun Chen, et al.
Pageof 15